Emil Kuriakose - 04 Jan 2022 Form 4 Insider Report for Calithera Biosciences, Inc.

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Emil Kuriakose
Issuer symbol
CALA on OTC
Transactions as of
04 Jan 2022
Net transactions value
-$2,546
Form type
4
Filing time
06 Jan 2022, 20:00:19 UTC
Previous filing
09 Nov 2021
Next filing
25 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALA Common Stock Tax liability $2,546 -3,855 -5.4% $0.6604 68,035 04 Jan 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 4, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F3 Includes 2,500 shares acquired on December 10, 2021, under the Company's 2014 Employee Stock Purchase Plan.